ArticleSubstance use : research and treatment
Bridging the Gap: A Secondary Data Analysis of Implementation Outcomes and Symptom Trajectories of an eHealth Mental Health and Parenting Treatment Among Mothers With and Without At-Risk Substance Use.
Article in Substance use : research and treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Several eHealth treatments, including the Building Emotional Awareness and Mental Health (BEAM) program, are feasible and effective for mothers with mental health concerns such as depression and/or anxiety. BEAM is a mental health and parenting program that does not directly address substance use. Prior BEAM trials observed high rates of alcohol and cannabis use among participants, despite not recruiting based on substance use. No research has examined BEAM among mothers with mental health concerns and at-risk substance use (ARSU), highlighting the need to understand implementation metrics and symptom trajectories among mothers with depression/anxiety and ARSU (ARSU+) and without ARSU (ARSU-). Objectives: To address this gap, we examined BEAM implementation metrics (retention, session attendance, perceived usefulness, safety) and mental health and parenting stress symptom trajectories over time in mothers with ARSU+ and ARSU-. Design: This was a secondary data analysis of 2 BEAM trials for mothers of infants (6-18 months) and toddlers (18-36 months). Methods: One-hundred-and-ten participants ( Results: Treatment adherence and safety benchmarks were met in both groups, the perceived usefulness benchmark was met only in the ARSU+ group, and the retention benchmark was not met for either group. Mental health and parenting stress symptom trajectories were largely similar between ARSU subgroups over time. Conclusion: This study extends evidence on BEAM by showing that mothers with ARSU+ can safely engage with BEAM, have acceptable treatment adherence, and describe BEAM as useful. Retention remains the key implementation barrier for mothers with ARSU+. Future BEAM iterations should prioritize retention-focused supports (eg, proactive engagement, incentives) to strengthen real-world impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.